UBS Group’s Innovator US Equity Accelerated Plus ETF July XTJL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-264
Closed -$10.3K 11262
2025
Q4
$10.3K Buy
+264
New +$10.1K ﹤0.01% 8235
2025
Q3
Sell
-214
Closed -$7.69K 11026
2025
Q2
$7.69K Sell
214
-195
-48% -$6.61K ﹤0.01% 9005
2025
Q1
$13.6K Buy
+409
New +$13.9K ﹤0.01% 8454
2024
Q3
Sell
-49
Closed -$1.54K 10136
2024
Q2
$1.54K Sell
49
-49
-50% -$1.52K ﹤0.01% 8555
2024
Q1
$3.02K Buy
+98
New +$2.96K ﹤0.01% 7785
2023
Q4
Sell
-26
Closed -$695 9965
2023
Q3
$695 Sell
26
-29
-53% -$797 ﹤0.01% 8329
2023
Q2
$1.51K Sell
55
-58
-51% -$1.54K ﹤0.01% 7904
2023
Q1
$2.9K Sell
113
-245
-68% -$6.06K ﹤0.01% 8420
2022
Q4
$8.38K Buy
+358
New +$8.28K ﹤0.01% 8779

Other funds holding XTJL

UBS Group's XTJL Position: Q1 2026 in Review

UBS Group sold out of Innovator US Equity Accelerated Plus ETF July (XTJL) in Q1 2026, closing a stake of 264 shares — an estimated $10.3K sold.

UBS Group first reported a position in XTJL in Q4 2022 and held it in 9 quarters. The position peaked at $13.6K in Q1 2025. 14 funds tracked by Wall St. Rank hold XTJL as of Q1 2026.

  • UBS Group reported no remaining Innovator US Equity Accelerated Plus ETF July position as of Q1 2026 after selling out during the quarter.
  • UBS Group sold 264 Innovator US Equity Accelerated Plus ETF July shares in Q1 2026, an estimated $10.3K.
  • UBS Group first reported a position in Innovator US Equity Accelerated Plus ETF July in Q4 2022 and held it in 9 quarters.
  • UBS Group's Innovator US Equity Accelerated Plus ETF July position peaked at $13.6K in Q1 2025.
  • 14 funds tracked by Wall St. Rank held Innovator US Equity Accelerated Plus ETF July as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.